VIYASH vs WOCKPHARMA: Stock Comparison

VIYASH SCIENTIFIC vs WOCKHARDTUpdated 4 Sept 26, 4:08 PM ISTNSE & company filings

WOCKHARDT is the larger company by market capitalisation. VIYASH SCIENTIFIC shows a lower P/E, lower leverage and a higher net margin, while WOCKHARDT shows a higher ROE, faster revenue growth and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

VIYASH leads 6; WOCKPHARMA leads 5 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

VIYASHWOCKPHARMA

Valuation lens

What price are you paying?

Market CapContext only
₹11,621 Cr
₹33,908 Cr
P/E RatioVIYASH has the lower reading
61.87x
75.68x
P/B RatioVIYASH has the lower reading
3.87x
6.27x
EPSWOCKPHARMA has the higher reading
₹1.51
₹6.58
Book ValueContext only
₹71.3
₹325
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
WOCKPHARMA is the larger company
₹33,908 Cr vs ₹11,621 Cr
P/E Ratio
VIYASH has a lower P/E
61.87x vs 75.68x
P/B Ratio
VIYASH has a lower P/B
3.87x vs 6.27x
EPS
WOCKPHARMA has higher earnings per share
₹6.58 vs ₹1.51
Revenue Growth (TTM YoY)
WOCKPHARMA has faster revenue growth
26% vs 0%
Qtr Sales Growth
VIYASH has stronger quarterly sales growth
167.57% vs -39.61%
Qtr Profit Growth
VIYASH has stronger quarterly profit growth
279.02% vs 0%
ROE
WOCKPHARMA has a higher ROE
10.28% vs 1.32%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricVIYASHWOCKPHARMA
SectorHealthcare
IndustryPharmaceuticals

Price

MetricVIYASHWOCKPHARMA
Live Price₹265.85₹2,088.7
Day Change2.07%7.08%
Volume33.14 L35.58 L
52-Week High₹298₹2,422.3
52-Week Low₹178.13₹1,086.7
Distance from 52W High-10.79%-13.77%

Valuation

MetricVIYASHWOCKPHARMA
Market Cap₹11,621 Cr₹33,908 Cr
P/E Ratio61.87x75.68x
P/B Ratio3.87x6.27x
EPS₹1.51₹6.58
Book Value₹71.3₹325
Dividend Yield0%0%

Growth

MetricVIYASHWOCKPHARMA
Revenue Growth (TTM YoY)0%26%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth167.57%-39.61%
Qtr Profit Growth279.02%0%

Profitability & Leverage

MetricVIYASHWOCKPHARMA
ROE1.32%10.28%
ROCE1.76%10.37%
Net Margin6.57%3.3%
Operating Margin9.69%28.35%
Debt to Equity0.01x0.57x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricVIYASHWOCKPHARMA
Promoter Holding0%49.08%
FII Holding4.5% 1.56 pp7.22% 0.13 pp
DII Holding3.75% 4.24 pp9.24% 1.72 pp
Public Holding30.34% 2.67 pp34.44% 1.61 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: VIYASH SCIENTIFIC and WOCKHARDT.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.